Federico Mingozzi
Chief Tech/Sci/R&D Officer at SPARK THERAPEUTICS, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Khalil Barrage | M | 59 | - | |
| John Furey | M | 59 | 8 years | |
| Ron Philip | M | - | 7 years | |
| Julien Miara | M | - | - | |
| Cédric Moreau | M | 37 | - | |
| Eric Forquenot de la Fortelle | M | - | 9 years | |
| Aniz Girach | M | 57 | 2 years | |
| Jennifer Flaisher | F | - | 7 years | |
| Valerie Salentey | M | - |
Genethon
 Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | 7 years |
| Noémie Djokovic | F | - | - | |
| Nawal Ouzren | F | 45 | 7 years | |
| Natalie Berner | F | 34 | - | |
| Sean Johnston | M | - | 5 years | |
| Chris Stevens | M | - | 2 years | |
| Blake Sprayberry | M | - | - | |
| Wendy Kouba | F | - | 3 years | |
| Denise Bradley | F | - | - | |
| Gallia Levy | M | - | - | |
| Michael Retterath | M | - | 4 years | |
| Judith Laredo | M | - | - | |
| Géraldine Honnet | M | - | 4 years | |
| Alexandre Lemoalle | M | - |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | 9 years |
| Bruce Resnick | M | - | 5 years | |
| Florian Reinaud | M | 51 | - | |
| Bernd Schmidt | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Katherine High | M | 72 | 7 years | |
| Steven Altschuler | M | 70 | 6 years | |
| Jeffrey D. Marrazzo | M | 46 | 9 years | |
| Charles Sigal | M | 72 | 5 years | |
| Joseph W. la Barge | M | 53 | 8 years | |
| Robert Perez | M | 59 | 1 years | |
| Anand Mehra | M | 48 | 5 years | |
| Lars Ekman | M | 74 | 5 years | |
| Stephen Webster | M | 63 | 5 years | |
| Vin Milano Milano | M | 60 | 5 years | |
| Lota Zoth | F | 64 | 3 years | |
| Ramzi Benamar | M | 51 | 3 years | |
| Amy Garabedian | F | - | 5 years | |
| Derek Hicks | M | 51 | 1 years | |
| Cynthia Pussinen | F | - | 1 years | |
| Kathleen Reape | M | 58 | 4 years | |
| Hari Pujar | M | - | - | |
| Ryan Asay | M | - | 3 years | |
| Matthias Hebben | M | - |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | 6 years |
| Thomas Ciulla | M | 59 | 1 years | |
| Daniel Faga | M | 44 | 3 years | |
| Fulvio Mavilio | M | - |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | 5 years |
| Monique da Silva | F | - | 4 years | |
| Michael Gerard | M | 44 | 1 years | |
| Guillaume Michaloux | M | - |
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 33 | 66.00% |
| France | 18 | 36.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Federico Mingozzi
- Personal Network